×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
INTS – intensity therapeutics, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
INTS
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/12
08:17 am
ints
Intensity Therapeutics, Inc. and The Swiss Group for Clinical Cancer Research SAKK Present Phase 2 Data in Presurgical Breast Cancer from the completed INVINCIBLE-2 Study, and an Overview of the Ongoing Randomized, Presurgical Triple Negative Breast Cance
Medium
Report
Intensity Therapeutics, Inc. and The Swiss Group for Clinical Cancer Research SAKK Present Phase 2 Data in Presurgical Breast Cancer from the completed INVINCIBLE-2 Study, and an Overview of the Ongoing Randomized, Presurgical Triple Negative Breast Cance
12/12
08:00 am
ints
Intensity Therapeutics, Inc. and The Swiss Group for Clinical Cancer Research SAKK Present Phase 2 Data in Presurgical Breast Cancer from the completed INVINCIBLE-2 Study, and an Overview of the Ongoing Randomized, Presurgical Triple Negative Breast Cance
High
Report
Intensity Therapeutics, Inc. and The Swiss Group for Clinical Cancer Research SAKK Present Phase 2 Data in Presurgical Breast Cancer from the completed INVINCIBLE-2 Study, and an Overview of the Ongoing Randomized, Presurgical Triple Negative Breast Cance
11/21
08:06 am
ints
Intensity Therapeutics, Inc. Announces Pricing of $3 Million Registered Direct Offering and Concurrent Private Placement [Yahoo! Finance]
Medium
Report
Intensity Therapeutics, Inc. Announces Pricing of $3 Million Registered Direct Offering and Concurrent Private Placement [Yahoo! Finance]
11/21
08:00 am
ints
Intensity Therapeutics, Inc. Announces Pricing of $3 Million Registered Direct Offering and Concurrent Private Placement
Medium
Report
Intensity Therapeutics, Inc. Announces Pricing of $3 Million Registered Direct Offering and Concurrent Private Placement
11/18
08:12 am
ints
Intensity Therapeutics Presents INT230-6 Phase 1/2 Data in Sarcoma and an Overview of its Ongoing Global Randomized Phase 3 Sarcoma Trial ("INVINCIBLE-3 Study") in a Late-Breaking Session at the 2024 Annual Connective Tissue Oncology Society Meeting (CTOS
Medium
Report
Intensity Therapeutics Presents INT230-6 Phase 1/2 Data in Sarcoma and an Overview of its Ongoing Global Randomized Phase 3 Sarcoma Trial ("INVINCIBLE-3 Study") in a Late-Breaking Session at the 2024 Annual Connective Tissue Oncology Society Meeting (CTOS
11/18
08:00 am
ints
Intensity Therapeutics Presents INT230-6 Phase 1/2 Data in Sarcoma and an Overview of its Ongoing Global Randomized Phase 3 Sarcoma Trial ("INVINCIBLE-3 Study") in a Late-Breaking Session at the 2024 Annual Connective Tissue Oncology Society Meeting (CTOS
Low
Report
Intensity Therapeutics Presents INT230-6 Phase 1/2 Data in Sarcoma and an Overview of its Ongoing Global Randomized Phase 3 Sarcoma Trial ("INVINCIBLE-3 Study") in a Late-Breaking Session at the 2024 Annual Connective Tissue Oncology Society Meeting (CTOS
11/13
04:12 pm
ints
Intensity Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update [Yahoo! Finance]
Low
Report
Intensity Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update [Yahoo! Finance]
11/13
04:06 pm
ints
Intensity Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update
Low
Report
Intensity Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update
Date
Time
Symbol
Company Name
Action
%Chg
11/13/2024
04:06 pm
ints
intensity therapeutics, inc.
BEAT
Report
2.4%
intensity therapeutics, inc.
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
12/30
05:22 pm
ints
Form SCHEDULE 13G INTENSITY THERAPEUTICS, Filed by: SAPIENT CAPITAL LLC
Low
Report
Form SCHEDULE 13G INTENSITY THERAPEUTICS, Filed by: SAPIENT CAPITAL LLC
12/20
04:01 pm
ints
Form 424B3 INTENSITY THERAPEUTICS,
Medium
Report
Form 424B3 INTENSITY THERAPEUTICS,
12/20
06:03 am
ints
Form EFFECT INTENSITY THERAPEUTICS,
Low
Report
Form EFFECT INTENSITY THERAPEUTICS,
12/13
04:01 pm
ints
Form S-1 INTENSITY THERAPEUTICS,
Low
Report
Form S-1 INTENSITY THERAPEUTICS,
12/5
11:17 am
ints
Form D INTENSITY THERAPEUTICS,
Medium
Report
Form D INTENSITY THERAPEUTICS,
11/22
06:15 am
ints
Form 424B5 INTENSITY THERAPEUTICS,
Medium
Report
Form 424B5 INTENSITY THERAPEUTICS,
11/22
06:02 am
ints
Form 8-K INTENSITY THERAPEUTICS, For: Nov 21
Medium
Report
Form 8-K INTENSITY THERAPEUTICS, For: Nov 21
11/20
05:21 pm
ints
Form 424B5 INTENSITY THERAPEUTICS,
Medium
Report
Form 424B5 INTENSITY THERAPEUTICS,
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: